Explore our materials

Filters

Results (5583)

Thomas Berg

Slideset

Workshop on HCV Therapy Advances – New Antivirals in Clinical Practice 2015

Decompensated Cirrhosis - Thomas Berg, MD

Slideset

Workshop on HCV Therapy Advances – New Antivirals in Clinical Practice 2015

Liver Cancer - Massimo Colombo, MD

Slideset

Workshop on HCV Therapy Advances – New Antivirals in Clinical Practice 2015

Next Generation Regimens - Joost Drenth, MD

Rafael Esteban

Slideset

Workshop on HCV Therapy Advances – New Antivirals in Clinical Practice 2015

Panel Debate - Rafael Esteban, MD

Slideset

Workshop on HCV Therapy Advances – New Antivirals in Clinical Practice 2015

Approved Regimens for Cirrhotic Patients - Marina Berenguer

Slideset

Workshop on HCV Therapy Advances – New Antivirals in Clinical Practice 2015

Approved Regimens for Non ‐Cirrhotic Patients - Graham Foster, FRCP, PhD

Slideset

International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2014

Real-time and non-invasive, multi-compartment pharmacokinetics of 11c-rifampin in mycobacterium tuberculosis infected mice using dynamic positron emission tomography - V.P. DeMarco

Slideset

International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2014

Computational pharmacology of rifampin in mice: an application to dose optimization with conflicting objectives in tuberculosis treatment - M. Lyons

Slideset

International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2014

Anti-Tuberculosis Activity of Pyrazinamide Varies by Lesion Type in C3heb/Fej Mice - Lanoix, J.-P

Slideset

International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2014

Intra cavitary penetration of levofloxacin among patients with multidrug-resistant tuberculosis - R. Kempker

Slideset

International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2014

Inhaled Therapy for TB - Edward Nardell, MD

Slideset

International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2014

Explore our materials

Your Selection Clear All

Topic

Material Type

Event

Decompensated Cirrhosis - Thomas Berg, MD

Liver Cancer - Massimo Colombo, MD

Next Generation Regimens - Joost Drenth, MD

Panel Debate - Rafael Esteban, MD

Approved Regimens for Cirrhotic Patients - Marina Berenguer

Approved Regimens for Non ‐Cirrhotic Patients - Graham Foster, FRCP, PhD

Real-time and non-invasive, multi-compartment pharmacokinetics of 11c-rifampin in mycobacterium tuberculosis infected mice using dynamic positron emission tomography - V.P. DeMarco

Computational pharmacology of rifampin in mice: an application to dose optimization with conflicting objectives in tuberculosis treatment - M. Lyons

Anti-Tuberculosis Activity of Pyrazinamide Varies by Lesion Type in C3heb/Fej Mice - Lanoix, J.-P

Intra cavitary penetration of levofloxacin among patients with multidrug-resistant tuberculosis - R. Kempker

Inhaled Therapy for TB - Edward Nardell, MD

Pharmacological Knowledge Gaps in the Treatment of TB Meningitis - Guy Thwaites, MA, MBBS, PhD, FRCP, FRCPath, FMedSci